Oura Sells Quiet Health Data for Up to €529

The Oura Ring 5 costs between €429 and €529, before a subscription fee, and measures heart rate, heart-rate variability, skin temperature, breathing and movement. The screenless device doesn’t flash notifications at its wearer. Instead, its software turns biometric readings into estimates of sleep, activity, stress and recovery, then offers scores and recommendations. The pitch is health on your terms. The business combines a paid device, a subscription and a stream of data collected quietly, including through the night.

A dashboard without a screen

Screenless trackers such as Oura, wrist-worn Whoop and ring-shaped Ultrahuman are attracting consumers who want biometric data gathered unobtrusively and shown when they choose to check it. Apple Watch and Garmin’s bulkier multisport watches offer a contrast: they can display live information and notifications. These devices collect; their wearers consult the interpretation later.

Tito Mauna, a high-performance coach and lifestyle consultant, described a shift in focus: “We have gone from the era of 'how much I train' to the era of 'how do I recover,'” he said. He argued that stress affects muscle mass, cortisol and decision-making, and that a screen-free device avoids putting a flashing number or graph in front of someone during dinner. “The ring collects millions of biometric data silently during the night and gives you the diagnosis right when you wake up.”

That diagnosis isn’t a doctor’s order, but the software offers indicators, scores and recommendations to inform decisions about training intensity, rest and unusual lifestyle changes. Oura CEO Tom Hale framed the relationship as personal control: “It's about people becoming the CEO of their own health. Patriarchy in medicine is dead. We don't tell you what to do, we give you the information and you decide what to do with it.” The company sells tools for those choices, at a price and with a subscription fee.

The business behind the ring

Founded in 2013, Finnish company Oura was an early adopter of finger-based photoplethysmogram signals. The article says blood vessels in fingers produce a cleaner and more precise signal than capillaries on the back of the wrist. The product category has also shifted from counting steps toward interpreting heart-rate variability to assess recovery and help users decide whether to train or rest.

Oura’s commercial figures put its wellness language in sharper focus. The company confidentially registered its Form S-1 with the U.S. Securities and Exchange Commission on September 3, reporting turnover above $1.2 billion in the first half of the year and an estimated valuation of $16 billion. Wall Street expected an initial public offering. In late September, Oura’s board postponed it, citing market uncertainty, and chose to remain private despite strong investor demand.

From locker rooms to boardrooms

The trend now reaches hedge-fund traders and soccer players in Champions League locker rooms. Tennis player Taylor Fritz wore an Oura Ring on his middle finger at the 2026 US Open. Carlos Alcaraz wore a Whoop bracelet, but organizers banned him from wearing it at the Australian Open last January. These products sit between performance tracking and consumer health: they collect readings, interpret them and ask users to act on the results.

Tom Hale, described as a Silicon Valley veteran, joined the board after he became interested in the product during an insomnia crisis. His claim that users decide for themselves sits alongside a system that packages measurements into scores and recommendations, while the company sells both the hardware and subscription. The ring may stay out of sight. Its commercial model doesn’t.